|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
See Header: Sicca syndrome [Sjogren]
ICD-10 (CM) Code and Descriptor
|
M35.02 |
Sjogren syndrome with lung involvement
|
M3502 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 35.04%
|
25.48%
|
12.39%
|
8.38%
|
6.24%
|
3.89%
|
2.56%
|
2.11%
|
1.18%
|
0.75%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M35.02*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
437
|
440
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
341
|
342
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
292
|
292
|
|
80053
|
COMPREHEN METABOLIC PANEL |
264
|
264
|
|
86140
|
C-REACTIVE PROTEIN |
168
|
168
|
|
85652
|
RBC SED RATE AUTOMATED |
145
|
145
|
|
94729
|
CO/MEMBANE DIFFUSE CAPACITY |
110
|
110
|
|
86160
|
COMPLEMENT ANTIGEN |
89
|
143
|
|
82784
|
ASSAY IGA/IGD/IGG/IGM EACH |
71
|
115
|
|
85027
|
COMPLETE CBC AUTOMATED |
69
|
69
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
69
|
70
|
|
94010
|
BREATHING CAPACITY TEST |
65
|
65
|
|
82565
|
ASSAY OF CREATININE |
58
|
58
|
|
86235
|
NUCLEAR ANTIGEN ANTIBODY |
58
|
190
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
54
|
117
|
|
94726
|
PULM FUNCT TST PLETHYSMOGRAP |
54
|
54
|
|
96413
|
CHEMO IV INFUSION 1 HR |
52
|
52
|
|
J9312
|
INJ., RITUXIMAB, 10 MG |
51
|
3,610
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
51
|
72
|
|
84165
|
PROTEIN E-PHORESIS SERUM |
49
|
49
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M35.02 related to the following DRG Codes:
545-547
|
